We use cookies to enable the functions required for this website, such as login or a shopping cart. You can find more information in our privacy policy.
Frank Schwarz is Professor and Chairman of the Department of Oral Surgery and Implantology at the Centre for Dentistry and Oral Medicine (Carolinum), Johann Wolfgang Goethe-University Frankfurt, Germany. He serves as an Associate Editor for the Journal of Clinical Periodontology and Editorial Board Member for Periodontology 2000, Clinical Oral Implants Research and Clinical Implant Dentistry and Related Research. He is a Member of the Board of Directors of the European Association for Osseointegration – EAO, Executive Board Member of the Osteology Foundation, and Past President of the German Association of Oral Implantology (DGI). He was awarded the André Schröder Research Prize in 2007, the Miller Research Prize in 2012 and the Jan Lindhe Award in 2017.
Details make perfectionoctubre 24, 2024 — octubre 26, 2024MiCo - Milano Convention Centre, Milano, Italia
Ponentes: Bilal Al-Nawas, Gil Alcoforado, Federico Hernández Alfaro, Sofia Aroca, Wael Att, Gustavo Avila-Ortiz, Kathrin Becker, Anne Benhamou, Juan Blanco Carrión, Dieter Bosshardt, Daniel Buser, Francesco Cairo, Paolo Casentini, Raffaele Cavalcanti, Tali Chackartchi, Renato Cocconi, Luca Cordaro, Luca De Stavola, Nuno Sousa Dias, Egon Euwe, Vincent Fehmer, Alberto Fonzar, Helena Francisco, Lukas Fürhauser, German O. Gallucci, Oscar Gonzalez-Martin, Dominik Groß, Robert Haas, Alexis Ioannidis, Simon Storgård Jensen, Ronald Jung, France Lambert, Luca Landi, Georg Mailath-Pokorny jun., Silvia Masiero, Iva Milinkovic, Carlo Monaco, Jose Nart, José M. Navarro, Katja Nelson, Manuel Nienkemper, David Nisand, Michael Payer, Sergio Piano, Bjarni E. Pjetursson, Sven Reich, Isabella Rocchietta, Giuseppe Romeo, Irena Sailer, Mariano Sanz, Ignacio Sanz Martín, Frank Schwarz, Shakeel Shahdad, Massimo Simion, Ralf Smeets, Benedikt Spies, Bogna Stawarczyk, Martina Stefanini, Hendrik Terheyden, Tiziano Testori, Daniel Thoma, Ana Torres Moneu, Piero Venezia, Lukas Waltenberger, Hom-Lay Wang, Stefan Wolfart, Giovanni Zucchelli, Otto Zuhr
European Association for Osseintegration (EAO)
30th EAO Annual Scientific Meeting / 37th DGI Annual Congress
Berlin reloadedseptiembre 28, 2023 — septiembre 30, 2023CityCube Berlin, Berlin, Alemania
Ponentes: Samir Abou-Ayash, Bilal Al-Nawas, Thomas Bernhart, Florian Beuer, Stefan Bienz, Elena Calciolari, Najla Chebib, Andreas Dengel, Vincent Donker, Joke Duyck, Roberto Farina, Gary Finelle, Alberto Fonzar, Tobias Fretwurst, Rudolf Fürhauser, Oscar Gonzalez-Martin, Stefano Gracis, Knut A. Grötz, Christian Hammächer, Lisa J. A. Heitz-Mayfield, Detlef Hildebrand, Norbert Jakse, Jim Janakievski, Tim Joda, Daniel Jönsson, Gregg Kinzer, Vincent G. Kokich, Michael Krimmel, Cecilia Larsson Wexell, Martin Lorenzoni, Georg Mailath-Pokorny, Julia Mailath-Pokorny, Frank Georg Mathers, Gerry McKenna, Henny Meijer, Alberto Monje, Torsten Mundt, Nadja Nänni, David Nisand, Robert Nölken, Nicole Passia, Michael Payer, Christof Pertl, Aušra Ramanauskaitė, Eik Schiegnitz, Martin Schimmel, Ulrike Schulze-Späte, Frank Schwarz, Falk Schwendicke, Robert Stigler, Michael Stimmelmayr, Anette Strunz, Christian Ulm, Stefan Vandeweghe, Kay Vietor, Arjan Vissink, Asaf Wilensky, Stefan Wolfart, Werner Zechner, Anja Zembic, Nicola Zitzmann
European Association for Osseintegration (EAO)
European Prosthodontic Debates 2023
septiembre 14, 2023 — septiembre 16, 2023Radisson Blu Hotel Lietuva, Vilnius, Lituania
Ponentes: Rolandas Andrijauskas, Adomas Auskalnis, Kazuyoshi Baba, Tord Berglundh, Lawrence E. Brecht, Luigi Canullo, Farronato Davide , Luca De Stavola, Vincent Fehmer, Marco Ferrari, German O. Gallucci, Ieva Gendviliene, Simonas Grybauskas, Sascha Hein, Reinhilde Jacobs, Matthias Kern, Tomas Linkevičius, Diego Lops, Daniele Manfredini, Francesco Mangano, Magda Mensi, Eitan Mijiritsky, Suresh Nayar, Sam Omar, George Papavasiliou, Guillermo Pradíes, Algirdas Puišys, Aušra Ramanauskaitė, Daniele Rondoni, Dmitri Ruzanov, Irena Sailer, Frank Schwarz, Nicola Scotti, Tristan Staas, Eglė Vindašiūtė-Narbutė, Ulrich Wegmann, Lukasz Zadrozny, Ausra Znamenskaite-Levickiene
European Prosthodontic Association
3rd Urban International Hard and Soft Tissue Regeneration Symposium
Predictability in Regenerationoctubre 21, 2022 — octubre 22, 2022Budapest Congress Center, Budapest, Hungría
Ponentes: José Carlos Martins da Rosa, Luca De Stavola, Ueli Grunder, Jaime Lozada, Aušra Ramanauskaitė, Frank Schwarz, Istvan Urban, Giovanni Zucchelli, Otto Zuhr
Urban Regeneration Institute
Artículos de este autor en revistas
The International Journal of Prosthodontics, Pre-Print
DOI: 10.11607/ijp.8719, ID de PubMed (PMID): 38408133febrero 26, 2024,Páginas 1-20, Idioma: InglésLorenz, Jonas / Blume, Maximilian / Schwarz, Frank / Weigl, Paul / Ghanaati, Shahram / Sader, Rober A.
Purpose: Several procedures are performed to achieve optimal esthetic results in single-tooth
implants. However, there is discordance regarding the potential benefit and risks of immediate
implant loading/provisionalization. The aim of this prospective case series is to investigate
the effect of immediate provisionalization of single-tooth implants at healed sites for periimplant
soft-tissue conditions, focusing on papilla formation around single implants.
Materials and Methods: Twelve patients received a total of 12 implants in the incisor, canine
or premolar region of the upper and lower jaw at healed sites with immediate chair-side
provisionalization. Four months later, the temporary crown was replaced by the permanent
crown. After 40±13.1 months, clinical follow-up was conducted, assessing Probing pocket
depth (PPD); Bleeding on Probing(BoP); Mucosal recession (MR) and Width of Keratinized
Mucosa (KM). Papilla index (PI) was determined immediately after implant placement
(baseline), before removing the temporary crown (t1), 4 weeks after insertion of the definitive
crown (t2) and at the final follow-up examination (t3) to evaluate papilla formation and its
change over time. Results: None of the implants were lost. The mean PPD was 2.5±0.39 mm,
BoP of 25% and 3.5 mm of KM were observed at the final follow-up. No implants showed
MR. PI increased in all patients from 1.5±0.45 at baseline to 2.4±0.56 at t1, 2.6±0.47 at t2 and
3.02.6±0 at t3. The increase in PI between t0 and each individual timepoint from t1-t3 showed
statistical significance. Conclusion: The present results indicate the suitability and benefit of
immediate provisionalization to achieve favorable peri-implant soft-tissue conditions and
papilla formation.
International Journal of Periodontics & Restorative Dentistry, 4/2024
DOI: 10.11607/prd.6756, ID de PubMed (PMID): 37655972Páginas 466-476, Idioma: InglésBianchini, Marco Aurélio / Kuhlkamp, Lucas de Freitas / Schwarz, Frank / Galarraga-Vinueza, Maria Elisa
Diverse surgical approaches, such as resective, reconstructive, and combined therapy, have been proposed for peri-implantitis treatment. A resective surgical approach with an adjunctive modified implantoplasty refers to the modification of the implant body into a constricted area to mimic a “waist” silhouette. This modified technique forms an adequate concave smooth area that may favor the outcomes of resective surgical therapy for soft tissue adaptation, biofilm control, and possible peri-implant bone gain over the long term. The present case series aimed to exhibit the long-term clinical and radiographic outcomes of resective surgery with adjunctive implantoplasty over a 6- to 11-year follow-up. Four patients presenting four implants (one per patient) diagnosed with peri-implantitis (according to an established case definition) were included in the present case series. Patients underwent resective surgery, a modified implantoplasty approach, and implant surface decontamination. After surgical therapy, clinical and radiographic outcomes such as bleeding on probing (BoP), suppuration on probing (SoP), probing depth (PD), marginal recession (MR), modified plaque index (mPI), and marginal bone levels (MBLs) were recorded over a long-term follow-up period. Over the 6- to 11-year follow-up, mean BoP, PD, and SoP scores amounted to 17% ± 24%, 3.2 ± 0.66 mm, and 0%, respectively. Mean BoP, PD, and SoP scores were reduced by 67% ± 24%, 2.5 ± 1.26 mm, and 100%, respectively. Radiographic analysis revealed a mean radiographic bone gain of 3.1 ± 1.84 mm. Peri-implant marginal bone loss surface area decreased by 5.7 ± 3.77 mm2 over the long-term follow-up. Resective therapy with adjunctive implantoplasty promoted favorable clinical and radiographic outcomes at treated peri-implantitis sites over a long-term period.
Die Mundgesundheit der Menschen hat sich dank Fortschritten in der zahnärztlichen Rehabilitation weltweit verbessert, dies spiegelt sich in der Anzahl an zahnlosen Senioren wider. Für den zahnlosen Kiefer stehen verschiedene Therapiemöglichkeiten zur Verfügung. Implantatgestützter Zahnersatz bietet eine effektive Lösung und führt zu einer verbesserten Lebensqualität der Patienten. Anatomische Herausforderungen und die Qualität des Alveolarknochens beeinflussen den Erfolg dieser Behandlungsoptionen jedoch erheblich. Eine präzise Planung und enge Zusammenarbeit zwischen Behandler, Zahntechniker und Patienten, unter Berücksichtigung der genannten Faktoren, sind für den langfristigen Erfolg der zahnärztlichen Rehabilitation von zahnlosen oder teilbezahnten Patienten essenziell. Im Folgenden soll ein Fallbeispiel einer zahnlosen Patientin ausführlich dargestellt werden.
Palabras clave: zahnloser Kiefer, anatomische Strukturen, Implantatanzahl, Knochenaugmentation
Peri-implant diseases are defined as bacterial plaque-induced inflammatory conditions affecting implant-surrounding tissues and are classified as peri-implant mucositis and peri-implantitis. Peri-implant mucositis is characterized by an inflammatory lesion that resides in the soft tissue compartment, whereas at peri-implantitis sites the lesions also feature progressive loss of implant-supporting bone. Inflammation resolution and disease progression arrestment are the main therapeutic endpoints of the treatment of peri-implant diseases. The present position paper displays the current evidence and clinical recommendations of the European Association for Osseointegration for the treatment of peri-implant diseases. Mechanical biofilm removal along with the reinforcement of patient-administered oral hygiene is considered the standard treatment for managing peri-implant mucositis. It is recommended to assess the outcomes of peri-implant mucositis treatment 2 to 3 months after therapy, and repeated intervention should be considered in the absence of treatment success. Peri-implantitis treatment should follow a stepwise treatment approach, starting with nonsurgical treatment followed by surgical intervention, if that is not sufficient. Surgical peri-implantitis therapies include nonreconstructive, reconstructive, and combined treatment modalities. Implantoplasty may be advocated for the treatment of supracrestal peri-implant defects, whereas reconstructive therapy is indicated at peri-implantitis sites featuring intraosseous defects with a depth ≥ 3 mm. Adjunctive reconstructive measures may be beneficial in enhancing radiographic defect fill and maintaining postoperative soft tissue levels, which may have a great impact in esthetic cases. The adjunctive use of systemic antibiotics during surgical therapy does not seem to improve the clinical outcomes. Regular supportive peri-implant therapy with biofilm removal should be an integral part of the treatment protocol for peri-implant diseases. In the presence of advanced bone loss around implants that do not play a strategic role in masticatory function, implant removal may be considered immediately.
Implantate aus Zirkoniumdioxid erweisen sich als vielversprechende Alternative zu herkömmlichen Titanimplantaten. Eine 9-Jahres-Follow-up-Nachuntersuchung einer prospektiven klinischen Beobachtungsstudie dieser Arbeitsgruppe liefert weitere Daten zum Langzeiterfolg von Zirkoniumdioxid-Implantaten, welche in diesem Beitrag unter Bewertung der aktuell verfügbaren Literatur zusammenfassend dargestellt werden sollen.
Manuskripteingang: 15.08.2023, Annahme: 22.08.2023
Palabras clave: Zirkoniumdioxid-Implantate, Langzeitstudien, Titanimplantate, periimplantäre Mukositis, Periimplantitis
Gingivawucherung entpuppt sich als leukämische Zellinfiltration
Anzeichen einer Leukämie können sich in der Mundhöhle manifestieren. Deshalb kann die oralmedizinische Untersuchung eine essenzielle Bedeutung bei der Früherkennung hämatologischer Erkrankungen haben und den Ausgangspunkt für die Diagnose darstellen. Der vorliegende Fall zeigt, wie die Abklärung eines auffälligen Gingivabefunds zur Diagnose „akute myeloische Leukämie“ führte.
Manuskripteingang: 18.10.2021, Annahme: 18.11.2021
Originalpublikation: Obreja et al. (Zahnärztl Mitt 2022;112:220−225). Mit freundlicher Genehmigung des Deutschen Ärzteverlags.
Palabras clave: akute myeloische Leukämie, Gingivawucherung, orale Manifestationen, leukozytäres Manifestrat
Eine systematische Literaturübersicht und Bewertung von 80 Publikationen, einschließlich 55 randomisierter kontrollierter Studien und 7 klinischer Kontrollstudien, hat zu einer Neubewertung der Wirksamkeit von alternativen und adjuvanten Methoden zur nichtchirurgischen Therapie von periimplantärer Mukositis und Periimplantitis sowie der chirurgischen Therapie von Periimplantitis geführt. Diese Ergebnisse wurden verwendet, um die S3-Leitlinie zur „Behandlung von periimplantären Infektionen an Zahnimplantaten“ (Registernummer 083-023, V 2.0, Stand 02.12.2022) zu aktualisieren. In diesem Beitrag sollen die diagnostischen Kriterien für periimplantäre Infektionen sowie die Therapieziele unter Berücksichtigung klinischer und radiologischer Parameter dargestellt werden.
Manuskripteingang: 14.04.2023, Annahme: 19.04.2023
Palabras clave: periimplantäre Erkrankungen, periimplantäre Mukositis, Periimplantitis
Nicht rekonstruktive, rekonstruktive und kombinierte Verfahren
Eine systematische Literaturübersicht und Bewertung von 24 Publikationen, einschließlich 15 randomisierter kontrollierter Studien und 3 klinisch kontrollierter Studien, hat zu einer Neubewertung der Wirksamkeit der chirurgischen Therapie der Periimplantitis geführt. Diese Ergebnisse wurden verwendet, um die S3-Leitlinie zur „Behandlung von periimplantären Infektionen an Zahnimplantaten“ (Registernummer 083-023, V 2.0, Stand: 02.12.2022) zu aktualisieren. In diesem Beitrag sollen die nicht rekonstruktiven, rekonstruktiven und kombinierten Verfahren für die chirurgische Therapie der Periimplantitis dargestellt werden.
Manuskripteingang: 14.04.2023, Annahme: 20.04.2023
Palabras clave: periimplantäre Erkrankungen, Periimplantitis, chirurgische Therapie, rekonstruktive Therapie, Implantatplastik